CD47 and neoplasm: The investigation of TAMs has propelled the consideration of macrophages as targets for cancer therapy, particularly in clinical trials targeting CD47.20 The origin and dynamics of TAMs have been elucidated through fate mapping techniques, shedding light on their differentiation process within the tumor microenvironment.